About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hepatology
›
top-articles
Department of Hepatology
71
(top 1%)
papers
4.9K
(top 1%)
citations
28
(top 1%)
h
-index
65
(top 1%)
g
-index
75
all documents
5.2K
doc citations
1.2K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Nature Genetics
2012
1,229
2
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Gastroenterology
2012
736
3
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Journal of Hepatology
2017
734
4
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Lancet, The
2019
449
5
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
Gastroenterology
2014
232
6
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
Annals of the Rheumatic Diseases
2016
136
7
PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT
European Journal of Nuclear Medicine and Molecular Imaging
2006
128
8
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension
Journal of Viral Hepatitis
2017
107
9
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Journal of Hepatology
2017
100
10
Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort study
Journal of Hepatology
2009
98
11
Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States
Hepatology
2017
93
12
Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?
Annals of Hematology
2009
65
13
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis
Clinical Gastroenterology and Hepatology
2019
63
14
Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection
Clinical Gastroenterology and Hepatology
2013
61
15
Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
Digestive and Liver Disease
2012
57
16
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
JHEP Reports
2021
55
17
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent‐to‐treat analysis
Liver Transplantation
2017
54
18
Comparison of transient elastography (
FibroScan
),
FibroTest
,
APRI
and two algorithms combining these non‐invasive tests for liver fibrosis staging in
HIV
/
HCV
coinfected patients:
ANRS CO13 HEPAVIH
and
FIBROSTIC
collaboration
HIV Medicine
2014
50
19
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival
European Radiology
2011
49
20
Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcome
Journal of Hepatology
2012
46
21
Evaluation of the Architect® tacrolimus assay in kidney, liver, and heart transplant recipients
Journal of Pharmaceutical and Biomedical Analysis
2010
42
22
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
Liver International
2011
42
23
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis
Liver International
2018
40
24
Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis
Haematologica
2015
39
25
Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents
European Radiology
2003
34
26
Liver tumours in patients with Fanconi anaemia: a report of three cases
European Journal of Gastroenterology and Hepatology
2008
32
27
Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular‐cholangiocarcinoma
Liver International
2019
32
28
Ultra‐short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutrition
Liver International
2018
30
29
Oral Antibiotics Reduce Intestinal Necrosis in Acute Mesenteric Ischemia: A Prospective Cohort Study
American Journal of Gastroenterology
2019
28
30
Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit
Annals of Surgical Oncology
2017
26
31
Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE–PVE: a comparative study
Surgical Endoscopy and Other Interventional Techniques
2017
26
32
Endpoints and New Options for Treatment of Chronic Hepatitis D
Hepatology
2021
26
33
Prospective evaluation of the management of hepatocellular carcinoma in the elderly
Digestive and Liver Disease
2011
22
34
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
Journal of Hepatology
2015
19
35
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
Annals of Hepatology
2015
18
36
LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather
Journal of Hepatology
2015
18
37
Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference
Gut
2017
16
38
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd–Chiari syndrome
Journal of Hepatology
2011
12
39
Factors and Mechanisms Involved in Acquired Developmental Defects of Enamel: A Scoping Review
Frontiers in Pediatrics
2022
12
40
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
JHEP Reports
2020
11
41
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Liver International
2020
10
42
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
Clinics and Research in Hepatology and Gastroenterology
2021
10
43
Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolism
Biomedical Reports
2017
9
44
VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis
Thrombosis Research
2010
8
45
P0795 : Safety and efficacy of sofosbuvir-containing regimens in the French observational cohort ANRS CO22 HEPATHER
Journal of Hepatology
2015
8
46
Hepatopulmonary syndrome-attributed extreme hypoxemia and polycythemia revealing liver cirrhosis
American Journal of Emergency Medicine
2019
8
47
Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case report
Annals of Oncology
2020
8
48
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma
British Journal of Surgery
2022
7
49
Liver transplantation for hepatocellular carcinoma: Time for an international consensus
Clinics and Research in Hepatology and Gastroenterology
2012
6
50
Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib
Annals of Oncology
2018
6
site/software ©
exaly
; All materials licenced under
CC by-SA
.